TrialArchives of dermatological research2024

Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.

Eric L Simpson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.